What does absent fructose in a semen analysis indicate and what are the recommended diagnostic and therapeutic steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Absent Fructose in Semen Analysis: Diagnostic Significance and Management

What Absent Fructose Indicates

Absent or low fructose in semen analysis indicates obstruction or absence of the seminal vesicles or ejaculatory ducts, most commonly seen in congenital bilateral absence of the vas deferens (CBAVD) or ejaculatory duct obstruction (EDO). 1

Fructose is produced exclusively by the seminal vesicles, making it a specific marker for seminal vesicle function and patency of the distal reproductive tract. 2, 3

Key Diagnostic Pattern

The classic triad that confirms distal obstruction includes: 1

  • Low ejaculate volume (<1.4 mL)
  • Acidic pH (<7.0)
  • Azoospermia with absent or low fructose

This pattern is "typically indicative of distal obstruction in the genital tract" and is commonly seen in CBAVD or EDO. 1

Diagnostic Workup

Initial Confirmation

  • Obtain at least two semen analyses one month apart to confirm the finding, as semen parameters are highly variable biological measures. 1
  • Measure seminal fructose levels quantitatively if not already done; absent fructose is defined as levels below normal reference ranges. 4

Physical Examination

Perform a focused genital examination looking for: 1

  • Palpation of the vas deferens bilaterally in the spermatic cord—absence confirms CBAVD
  • Testicular size and consistency—normal-sized testes (15-25 mL) with absent vas suggests obstructive pathology rather than testicular failure
  • Epididymal examination—dilated or indurated epididymides suggest obstruction

Hormonal Assessment

Measure serum FSH levels: 1

  • FSH <7.6 IU/L supports obstructive azoospermia (normal spermatogenesis with blockage)
  • FSH ≥7.6 IU/L suggests non-obstructive azoospermia (testicular failure), which would be inconsistent with isolated absent fructose

Genetic Testing

In confirmed CBAVD, genetic evaluation is mandatory: 1

  • CFTR gene mutation analysis—CBAVD is strongly associated with cystic fibrosis transmembrane conductance regulator mutations
  • Partner screening for CFTR mutations should be offered before assisted reproduction

Important Clinical Distinctions

Seminal Vesicle Status in CBAVD

Despite absent fructose, many men with CBAVD actually have intact seminal vesicles. A study found seminal vesicles present bilaterally in 46% of men with absent vas deferens, suggesting that "negative semen fructose and low ejaculate volume in men with absence of the vas deferens may be owing to agenesis or obstruction of the ejaculatory ducts rather than absent seminal vesicles." 5

Confirmatory Evidence

Low volume ejaculate with azoospermia and low or absent semen fructose is sufficient corroborative evidence for vas aplasia, and no further investigations are required for this diagnosis. 4 The clinical diagnosis was found correct in 100% of cases in a prospective study. 4

Imaging Considerations

Transrectal ultrasound (TRUS) or pelvic MRI should be considered only when: 6

  • Ejaculatory duct obstruction is suspected (to visualize dilated seminal vesicles or ejaculatory duct cysts)
  • Physical examination findings are equivocal
  • Surgical intervention is being contemplated

However, imaging was non-contributory in 30-50% of evaluations and is not required when the clinical diagnosis is clear. 4

Therapeutic Options

For CBAVD (Surgically Uncorrectable)

Sperm retrieval techniques are the only fertility option: 4

  • Testicular sperm extraction (TESE) or microsurgical TESE
  • Percutaneous epididymal sperm aspiration (PESA) or microsurgical epididymal sperm aspiration (MESA)
  • Followed by intracytoplasmic sperm injection (ICSI) for assisted reproduction

For Ejaculatory Duct Obstruction (Potentially Correctable)

  • Transurethral resection of the ejaculatory ducts (TURED) may restore antegrade ejaculation in selected cases
  • Success depends on accurate diagnosis and appropriate patient selection

Critical Pitfalls to Avoid

  • Do not assume absent seminal vesicles based solely on absent fructose—imaging may reveal intact vesicles with ductal obstruction. 5
  • Do not confuse with retrograde ejaculation—check post-ejaculatory urine for sperm if volume is low but vas deferens are palpable. 1
  • Do not order extensive imaging when clinical diagnosis is clear—physical examination showing absent vas with azoospermia and absent fructose is diagnostic. 4
  • Always perform CFTR testing in CBAVD before proceeding with assisted reproduction—critical for genetic counseling and partner screening. 1

References

6
Guideline

Elevated Follicle‑Stimulating Hormone (FSH) and Testicular Reserve: Evidence‑Based Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In a 71-year-old female with unintentional weight loss of 20 lb over 6 months, who is a cigarette smoker and has pre‑existing diabetes, what differential diagnoses should be considered?
In a 72‑year‑old patient with type 2 diabetes mellitus, psoriatic arthritis, a knee prosthesis, HbA1c 72 mmol/mol (previously 46), CRP 44 mg/L (previously 9‑10), unintended 20 kg weight loss, dark urine, and a mildly elevated white‑cell count, how should I manage his diabetes and investigate the underlying cause?
How do I perform a 75‑gram oral glucose tolerance test (OGTT)?
How should a 79-year-old patient with diabetes who has had nocturia and increased thirst for the past month be evaluated and managed?
What discharge plan should be recommended for a postpartum woman, two days after delivery, with type 2 diabetes on insulin glargine (Lantus) 9 U daily without carbohydrate coverage, who is breastfeeding and currently has hyperglycemia?
Is colistin (polymyxin E) appropriate for treating a Burkholderia cepacia complex infection?
What is the appropriate treatment for genital warts (condyloma acuminata) on the penis and scrotum?
I am on tirzepatide (Mounjaro) and have rapid weight loss with back and leg pain/stiffness—could this be sciatica, peroneal nerve compression/neuropathy, a vitamin deficiency, or another issue, and should I continue, hold, or avoid increasing the dose, and what tests and nutrition/protein plan are recommended?
What is the best antibiotic regimen for an adult with a groin abscess?
What is the appropriate management of methemoglobinemia in a patient with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency?
How should incidentally detected medullary nephrocalcinosis be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.